General Atlantic, L.P. revealed in an SEC filing dated November 13, 2025, that it purchased 500,000 additional shares of Pharvaris (NASDAQ: PHVS), increasing its stake by approximately $67.83 million. Following this acquisition, General Atlantic’s total holdings in Pharvaris amount to 8,031,252 shares, valued at $200.38 million as of September 30, 2025. This investment now constitutes 6.0% of the firm’s $3.33 billion reportable assets under management (AUM).
